Xmoor Pharma has established a strategic collaboration with the Translational Research Office (TRO) and University College ...

The status could support staged transitions to new manufacturing processes, potentially mitigating some risks of high-stakes ...

Ori Biotech has lassoed a significant milestone for its space- and cost-efficient cell and gene therapy manufacturing platform. The FDA has granted the company’s IRO platform an Advanced Manufacturing ...

Pressure to make cell and gene therapies more affordable will force the industry to overcome its reticence and embrace closed production systems, automation, and artificial intelligence (AI). So says, ...

ST. PAUL, Minn., Sept. 9, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that eight (8) G-Rex ...

The chief medical officer of Genetix Biotherapeutics, formerly known as Bluebird bio, discusses timelines and operational ...

Two recent studies show the novel therapy works in people with multiple myeloma, but researchers are trying to minimize side ...

According to MarketsandMarkets™, the Cell Therapy Technologies Market is projected to grow from about USD 4.41 billion in 2025 to USD 7.91 million by 2030, at a CAGR of 12.4%.

Easily one of the quickest developing spaces in the pharma space right now, cell and gene therapies are becoming increasingly investigated in a variety of indications. The year 2024 started with a ...

A study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia offers ...

Charles River Laboratories International Inc. has announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP).